British Journal of Pharmacy

British Journal of Pharmacy British Journal of Pharmacy is not-for-profit, online peer-reviewed open access journal offering gol

MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults...
24/07/2024

MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults. Semaglutide becomes the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease. Medicines & Healthcare products Regulatory Agency

Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease

Adresse

Mobile

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque British Journal of Pharmacy publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter L'entreprise

Envoyer un message à British Journal of Pharmacy:

Partager

Type